These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 18290749)

  • 1. The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals.
    Tegger MK; Crane HM; Tapia KA; Uldall KK; Holte SE; Kitahata MM
    AIDS Patient Care STDS; 2008 Mar; 22(3):233-43. PubMed ID: 18290749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.
    Pence BW; Miller WC; Gaynes BN; Eron JJ
    J Acquir Immune Defic Syndr; 2007 Feb; 44(2):159-66. PubMed ID: 17146374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.
    Chander G; Himelhoch S; Moore RD
    Drugs; 2006; 66(6):769-89. PubMed ID: 16706551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders.
    Mijch A; Burgess P; Judd F; Grech P; Komiti A; Hoy J; Lloyd JH; Gibbie T; Street A
    HIV Med; 2006 May; 7(4):205-12. PubMed ID: 16630032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
    Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults.
    Nachega JB; Mutamba B; Basangwa D; Nguyen H; Dowdy DW; Mills EJ; Katabira E; Nakimuli-Mpungu E
    Trop Med Int Health; 2013 Jan; 18(1):53-7. PubMed ID: 23136882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans.
    Nurutdinova D; Chrusciel T; Zeringue A; Scherrer JF; Al-Aly Z; McDonald JR; Overton ET
    AIDS; 2012 Jan; 26(2):229-34. PubMed ID: 22089375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use.
    Chander G; Himelhoch S; Fleishman JA; Hellinger J; Gaist P; Moore RD; Gebo KA
    AIDS Care; 2009 May; 21(5):655-63. PubMed ID: 19444675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV patients with psychiatric disorders are less likely to discontinue HAART.
    Himelhoch S; Brown CH; Walkup J; Chander G; Korthius PT; Afful J; Gebo KA
    AIDS; 2009 Aug; 23(13):1735-42. PubMed ID: 19617816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
    J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection.
    Tucker JS; Burnam MA; Sherbourne CD; Kung FY; Gifford AL
    Am J Med; 2003 May; 114(7):573-80. PubMed ID: 12753881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients.
    Horberg MA; Silverberg MJ; Hurley LB; Towner WJ; Klein DB; Bersoff-Matcha S; Weinberg WG; Antoniskis D; Mogyoros M; Dodge WT; Dobrinich R; Quesenberry CP; Kovach DA
    J Acquir Immune Defic Syndr; 2008 Mar; 47(3):384-90. PubMed ID: 18091609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of HIV care for patients with serious mental illness.
    Bogart LM; Fremont AM; Young AS; Pantoja P; Chinman M; Morton S; Koegel P; Sullivan G; Kanouse DE
    AIDS Patient Care STDS; 2006 Mar; 20(3):175-82. PubMed ID: 16548714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
    Sterling TR; Chaisson RE; Moore RD
    AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of highly active antiretroviral therapy utilization for behaviorally HIV-1-infected youth: impact of adult versus pediatric clinical care site.
    Agwu AL; Siberry GK; Ellen J; Fleishman JA; Rutstein R; Gaur AH; Korthuis PT; Warford R; Spector SA; Gebo KA
    J Adolesc Health; 2012 May; 50(5):471-7. PubMed ID: 22525110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug use.
    Himelhoch S; Chander G; Fleishman JA; Hellinger J; Gaist P; Gebo KA
    Gen Hosp Psychiatry; 2007; 29(6):518-25. PubMed ID: 18022045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.
    Celentano DD; Galai N; Sethi AK; Shah NG; Strathdee SA; Vlahov D; Gallant JE
    AIDS; 2001 Sep; 15(13):1707-15. PubMed ID: 11546947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anhedonia and depressive symptomatology among HIV-infected patients with highly active antiretroviral therapies (ANRS-EN12-VESPA)].
    Préau M; Bonnet A; Bouhnik AD; Fernandez L; Obadia Y; Spire B;
    Encephale; 2008 Sep; 34(4):385-93. PubMed ID: 18922241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
    Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
    Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.